Spinal cord involvement in the nonhuman primate model of Lyme disease

Laboratory Investigation

Volumn 84, Issue 2, 2004, Pages 160-172

  Bai, Yunhong ^a,b   Narayan, Kavitha ^a   Dail, Donna ^a   Sondey, Marie ^a,b   Hodzic, Emir ^c   Barthold, Stephen W ^c   Pachner, Andrew R ^a   Cadavid, Diego ^a,b  

^a Department of Neurology and Neuroscience ^*  (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antibody; Borrelia burgdorferi; c1q; Garini; Lyme borreliosis; Spinal cord; Strains

Indexed keywords

COMPLEMENT COMPONENT C1Q; EOSIN; HEMATOXYLIN; ANTIINFLAMMATORY AGENT; BACTERIAL RNA; BACTERIUM ANTIBODY; DEXAMETHASONE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASEPTIC MENINGITIS; AUTOPSY; BACTERIAL STRAIN; BORRELIA BURGDORFERI; BORRELIA GARINII; BRAIN DISEASE; CONTROLLED STUDY; FACIAL NERVE PARALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LYME DISEASE; MACACA; MYELITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RADICULITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; ANIMAL; BITES AND STINGS; DISEASE MODEL; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; IMAGE PROCESSING; IMMUNE DEFICIENCY; IMMUNOLOGY; ISOLATION AND PURIFICATION; IXODES; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, BACTERIAL; BITES AND STINGS; BORRELIA BURGDORFERI; COMPLEMENT C1Q; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOCOMPROMISED HOST; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSION; IXODES; LYME NEUROBORRELIOSIS; MACACA MULATTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; SPINAL CORD;

EID: 1542504571     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700024     Document Type: Article

References (39)

1. Steere AC. Lyme disease [see comments]. N Engl J Med 2001;345:115-125.
2. Pachner AR, Cadavid D. Lyme neuroborreliosis. In: Griggs RC, Joynt RJ (eds). Clinical Neurology on CD ROM. Lippincott-Raven: Philadelphia, 2002.
3. Bannwarth A. Chronische lymphocytäre Meningitis, entzündliche Polyneuritis und Rheumatismus. Arch Psychiatr Nervenkr 1941;113:284-376.
4. Bannwarth A. Zur Klinic und Pathogenese der 'chronischen lymphocytären Meningitis'. Arch Psychiatr Nervenkr 1944;117:161-185.
5. Duray PH. The surgical pathology of human Lyme disease. An enlarging picture. Am J Surg Pathol 1987;ll(Suppl 1):47-60.
6. Busch U, Hizo-Teufel C, Boehmer R, et al. Three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. afzelii, and B. garinii) identified from cerebrospinal fluid isolates by pulsed-field gel electrophoresis and PCR. J Clin Microbiol 1996;34:1072-1078.
7. Cadavid D, Barbour AG. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Diseases 1998;26:151-164.
8. Pachner AR, Delaney E, O'Neill T, et al. Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease. Neurology 1995;45:165-172.
9. Pachner AR, Zhang WF, Schaefer H, et al. Detection of active infection in nonhuman primates with Lyme neuroborreliosis: comparison of PCR, culture, and a bioassay. J Clin Microbiol 1998;36:3243-3247.
10. Pachner AR, Amemiya K, Bartlett M, et al. Lyme borreliosis in rhesus macaques: effects of corticosteroids on spirochetal load and isotype switching of antiborrelia burgdorferi antibody. Clin Diagn Lab Immunol 2001;8:225-232.
11. Pachner AR, Delaney E, O'Neill T. Neuroborreliosis in the nonhuman primate: Borrelia burgdorferi persists in the central nervous system [see comments]. Ann Neurol 1995;38:667-669.
12. Pachner AR, Dail D, Li L, et al. Humoral immune response associated with lyme borreliosis in nonhuman primates: analysis by immunoblotting and enzyme-linked immunosorbent assay with sonicates or recombinant proteins. Clin Diagn Lab Immunol 2002;9:1348-1355.
13. Cadavid D, O'Neill T, Schaefer H, et al. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of lyme disease. Lab Invest 2000;80:1043-1054.
14. Pachner AR, Cadavid D, Shu G, et al. Central and peripheral nervous system infection, immunity, and inflammation in the NHP model of Lyme borreliosis. Ann Neurol 2001;50:330-338.
15. Moody KD, Barthold SW, Terwilliger GA. Lyme borreliosis in laboratory animals: effect of host species and in vitro passage of Borrelia burgdorferi. Am J Trop Med Hyg 1990;43:87-92.
16. Masuzawa T, Okada Y, Yanagihara Y. Protective activity of antisera against isolates of Borrelia burgdorferi from various geographical origins. Microbiol Immunol 1993;37:79-83.
17. Wilske B, Busch U, Eiffert H, et al. Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany. Med Microbiol Immunol (Berl) 1996;184:195-201.
18. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984;57:521-525.
19. Pachner AR, Delaney E, Zhang WF, et al. Protection from Lyme neuroborreliosis in nonhuman primates with a multiantigenic vaccine. Clin Immunol 1999;91:310-313.
20. Dressier F, Whalen JA, Reinhardt BN, et al. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993:167:392-400.
21. Pachner AR, Braswell ST, Delaney E, et al. A rabbit model of Lyme neuroborreliosis: characterization by PCR, serology, and sequencing of the OspA gene from the brain. Neurology 1994;44:1938-1943.
22. Lockridge KM, Sequar G, Zhou SS, et al. Pathogenesis of experimental rhesus cytomegalovirus infection. J Virol 1999;73:9576-9583.
23. Schmidt R, Kabatzki J, Hartung S, et al. Erythema migrans borreliosis in the Federal Republic of Germany. Epidemiology and clinical aspects. Dtsch Med Wochenschr 1985;110:1803-1807.
24. van Dam AP, Kuiper H, Vos K, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Diseases 1993;17:708-717.
25. Mantienne C, Albucher JF, Catalaa I, et al. MRI in Lyme disease of the spinal cord. Neuroradiology 2001;43:485-488.
26. Good CD, Jager HR. Contrast enhancement of the cerebrospinal fluid on MRI in two cases of spirochaetal meningitis. Neuroradiology 2000;42:448-450.
27. Engelter S, Lyrer P, Radu EW, et al. Acute infectious disorders of the spinal cord and its roots with gadolinium-DTPA enhancement in magnetic resonance imaging. J Neurol 1996;243:191-195.
28. Kruger H, Heim E, Schuknecht B, et al. Acute and chronic neuroborreliosis with and without CNS involvement: a clinical, MRI, and HLA study of 27 cases, [see comments]. J Neurol 1991;238:271-280.
29. Kohler J, Kern U, Kasper J, et al. Chronic central nervous system involvement in Lyme borreliosis. Neurology 1988;38:863-867.
30. Cadavid D, Thomas DD, Crawley R, et al. Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med 1994;179:631-642.
31. Cadavid D, Bai Y, Dail D, et al. Infection and inflammation in skeletal muscle from non-human primates infected with different genospecies of the Lyme disease spirochete Borrelia burgdorferi. Infect Immun 2003;71:7087-7098.
32. Roberts ED, Bohm Jr RP, Cogswell FB, et al. Chronic lyme disease in the rhesus monkey [see comments]. Lab Invest 1995;72:146-160.
33. van den Berg RH, Faber-Krol MC, Sim RB, et al. The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells. J Immunol 1998;161:6924-6930.
34. Grewal RP, Morgan TE, Finch CE. C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis. Neurosci Lett 1999;271:65-67.
35. Liu L, Tornqvist E, Mattsson P, et al. Complement and clusterin in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat. Neuroscience 1995;68:167-179.
36. Klein MA, Kaeser PS, Schwarz P, et al. Complement facilitates early prion pathogenesis. Nat Med 2001;7:488-492.
37. Dietzschold B, Schwaeble W, Schafer MK, et al. Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis. J Neurol Sci 1995;130:11-16.
38. Kalish RA, Kaplan RF, Taylor E, et al. Evaluation of study patients with Lyme disease, 10-20-year follow-up. J Infect Dis 2001;183:453-460.
39. Klempner MS. Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease. Vector Borne Zoonotic Dis 2002;2:255-263.